PatientsVille.com Logo

PatientsVille

Lamictin Side Effects

Common Lamictin Side Effects


The most commonly reported Lamictin side effects (click to view or check a box to report):

Pruritus (3)
Petit Mal Epilepsy (3)
Balance Disorder (2)
Stevens-johnson Syndrome (2)
Vertigo (2)
Oropharyngeal Pain (2)
Loss Of Consciousness (2)
Eye Irritation (2)
Swelling Face (1)
Myositis (1)
Swollen Tongue (1)
Tongue Disorder (1)
Leukocytoclastic Vasculitis (1)
Vomiting (1)
Abdominal Pain Upper (1)
Convulsion (1)
Abortion Induced (1)
Headache (1)
Hepatic Failure (1)
Ill-defined Disorder (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Lamictin Side Effects Reported to FDA

The following Lamictin reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Lamictin on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Convulsion, Pruritus, Psychomotor Hyperactivity, Decreased Appetite, Headache, Rash, Abdominal Pain Upper, Petit Mal Epilepsy
This is a report of a 13-year-old female patient (weight: NA) from ZA, suffering from the following symptoms/conditions: epilepsy, who was treated with Lamictin (dosage: NA, start time: 201301), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Convulsion
  • Pruritus
  • Psychomotor Hyperactivity
  • Decreased Appetite
  • Headache
  • Rash
  • Abdominal Pain Upper
  • Petit Mal Epilepsy
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Lamictin treatment in female patients, resulting in convulsion side effect.

Suicidal Ideation, Acne
This report suggests a potential Lamictin Suicidal Ideation, Acne side effect(s) that can have serious consequences. A 17-year-old male patient (weight: NA) from ZA was diagnosed with the following symptoms/conditions: depression and used Lamictin (dosage: NA) starting NS. Soon after starting Lamictin the patient began experiencing various side effects, including:
  • Suicidal Ideation
  • Acne
Drugs used concurrently:
  • Cipralex
Although Lamictin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as suicidal ideation, may still occur.

Blood Pressure Abnormal, Hepatic Failure
This Blood Pressure Abnormal, Hepatic Failure problem was reported by a pharmacist from SOUTH AFRICA. A 28-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Lamictin (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Lamictin, the patient experienced the following unwanted symptoms/side effects:
  • Blood Pressure Abnormal
  • Hepatic Failure
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as blood pressure abnormal, may become evident only after a product is in use by the general population.

Abortion Induced
This is a report of a 33-year-old female patient (weight: NA) from SOUTH AFRICA. The patient developed the following symptoms/conditions: epilepsy and was treated with Lamictin (dosage: 100mg Twice Per Day) starting NS. Concurrently used drugs:
  • Urbanyl (clobazam)
Soon after that, the consumer experienced the following side effects:
  • Abortion Induced
This opens a possibility that Lamictin treatment could cause the above reactions, including abortion induced, and some female subjects may be more susceptible.


Arthritis, Leukocytoclastic Vasculitis, Myositis
A 50-year-old female patient (weight: NA) from SOUTH AFRICA with the following symptoms/conditions: epilepsy started Lamictin treatment (dosage: 200mg Per Day) on NS. Soon after starting Lamictin treatment, the subject experienced various side effects, including:
  • Arthritis
  • Leukocytoclastic Vasculitis
  • Myositis
Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Lamictin.

Chest Discomfort, Dyspnoea, Pneumonia, Respiration Abnormal
A 37-year-old female patient from NORWAY (weight: NA) experienced symptoms, such as: NA and was treated with Lamictin(dosage: 300mg Per Day). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
  • Chest Discomfort
  • Dyspnoea
  • Pneumonia
  • Respiration Abnormal
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Lamictin efficacy:
  • Cipralex
  • Guaifenesin
  • Lithium


Nightmare
In this report, Lamictin was administered for the following condition: epilepsy.A male consumer from SOUTH AFRICA (weight: NA) started Lamictin treatment (dosage: 150mg Twice Per Day) on Oct 24, 2008.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Nightmare
A possible interaction with other drugs could have contributed to this reaction:
  • Trileptal
  • Ritalin
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Lamictin treatment could be related to the listed above side effect(s).

Balance Disorder, Loss Of Consciousness, Petit Mal Epilepsy, Vertigo
This is a report of the following Lamictin side effect(s):
  • Balance Disorder
  • Loss Of Consciousness
  • Petit Mal Epilepsy
  • Vertigo
A 43-year-old female patient from SOUTH AFRICA (weight: NA) presented with the following condition: epilepsy and received a treatment with Lamictin (dosage: 100mg Per Day) starting: Jan 01, 2008.The following concurrently used drugs could have generated interactions:
  • Valproate Sodium
This report suggests that a Lamictin treatment could be associated with the listed above side effect(s).


This Lamictin report was submitted by a 19-year-old female consumer from SOUTH AFRICA (weight: NA). The patient was diagnosed with: NA and Lamictin was administered (dosage: NA) starting: NS. The consumer developed a set of symptoms:
    Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Lamictin treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

    Aggression, Disturbance In Attention, Dry Mouth, Protrusion Tongue
    This is a report of a possible correlation between Lamictin use and the following symptoms/side effect(s):
    • Aggression
    • Disturbance In Attention
    • Dry Mouth
    • Protrusion Tongue
    which could contribute to an assessment of Lamictin risk profile.A 8-year-old female consumer from SOUTH AFRICA (weight: NA) was suffering from NA and was treated with Lamictin (dosage: NA) starting Nov 01, 2008.Other concurrent medications:
    • Topiramate


    Eye Irritation, Oropharyngeal Pain, Pruritus, Stevens-johnson Syndrome
    A 25-year-old female patient from SOUTH AFRICA (weight: NA) presented with the following symptoms: bipolar disorder and after a treatment with Lamictin (dosage: 12.5mg Per Day) experienced the following side effect(s):
    • Eye Irritation
    • Oropharyngeal Pain
    • Pruritus
    • Stevens-johnson Syndrome
    The treatment was started on NS. Lamictin was used in combination with the following drugs:
    • Arcoxia
    The patient was hospitalized.This report could alert potential Lamictin consumers.

    Eye Irritation, Oropharyngeal Pain, Pruritus, Stevens-johnson Syndrome
    In this report, a 25-year-old female patient from SOUTH AFRICA (weight: NA) was affected by a possible Lamictin side effect.The patient was diagnosed with bipolar disorder. After a treatment with Lamictin (dosage: 12.5mg Per Day, start date: NS), the patient experienced the following side effect(s):
    • Eye Irritation
    • Oropharyngeal Pain
    • Pruritus
    • Stevens-johnson Syndrome
    The following simultaneously used drugs could have led to this reaction:
    • Arcoxia
    The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Lamictin treatment.

    Balance Disorder, Loss Of Consciousness, Petit Mal Epilepsy, Vertigo
    This is a report of a 43-year-old female patient from SOUTH AFRICA (weight: NA), who used Lamictin (dosage: 100mg Per Day) for a treatment of epilepsy. After starting a treatment on Jan 01, 2008, the patient experienced the following side effect(s):
    • Balance Disorder
    • Loss Of Consciousness
    • Petit Mal Epilepsy
    • Vertigo
    The following drugs could possibly have interacted with the Lamictin treatment
    • Valproate Sodium
    Taken together, these observations suggest that a Lamictin treatment could be related to side effect(s), such as Balance Disorder, Loss Of Consciousness, Petit Mal Epilepsy, Vertigo.

    Aphasia, Drooling, Eczema, Ill-defined Disorder, Nausea, Swelling Face, Swollen Tongue, Tongue Disorder, Vomiting
    This aphasia side effect was reported by a physician from SOUTH AFRICA. A 9-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Lamictin (dosage: 75mg Twice Per Day), which was started on Dec 03, 2007. Concurrently used drugs: NA. When starting to take Lamictin the consumer reported the following symptoms:
    • Aphasia
    • Drooling
    • Eczema
    • Ill-defined Disorder
    • Nausea
    • Swelling Face
    • Swollen Tongue
    • Tongue Disorder
    • Vomiting
    These side effects may potentially be related to Lamictin.



    Keep Track of Side Effects

    Note Your Observations

    It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

    Why Your Notes are Important

    Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Lamictin Side Effects

    Did You Have a Lamictin Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Lamictin for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Lamictin Safety Alerts, Active Ingredients, Usage Information

    More About Lamictin

    Side Effects reported to FDA: 14

    Lamictin safety alerts: No

    Reported deaths: 2

    Reported hospitalizations: 4

    Latest Lamictin clinical trials